Tiziana Pressiani
10PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Apr 09, 2025
ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab.Bernardo Stefanini, Claudia Angela Maria Fulgenzi, Bernhard Scheiner
|Oct 18, 2024
Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial.Teresa Macarulla, Zhenggang Ren, Hong Jae Chon
|Oct 09, 2023
Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma.Valentina Zanuso, Angelo Pirozzi, Rita Balsano
|Sep 21, 2022
Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights.Antonella Cammarota, Valentina Zanuso, Tiziana Pressiani
|Feb 14, 2022
The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials.Antonella Cammarota, Valentina Zanuso, Antonio D'Alessio
|Jan 24, 2022
Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials.Antonella Cammarota, Valentina Zanuso, Antonio D'Alessio
Pageof 2
Frequent Collaborators
9 joint publications
Lorenza Rimassa
5 joint publications
Antonella Cammarota
5 joint publications
Antonio D'Alessio
5 joint publications
Nicola Personeni
5 joint publications
Valentina Zanuso
2 joint publications
Antonio Sica
2 joint publications
Hong Jae Chon
1 joint publications
Giulia Soldà
1 joint publications
Mario P Colombo
1 joint publications
Silvia Bozzarelli
